97 related articles for article (PubMed ID: 21624510)
1. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay.
Cho CK; Drabovich AP; Batruch I; Diamandis EP
J Proteomics; 2011 Sep; 74(10):2052-9. PubMed ID: 21624510
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
[TBL] [Abstract][Full Text] [Related]
3. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
Cho CK; Smith CR; Diamandis EP
J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic analysis of human amniotic fluid supernatants with Down syndrome using mass spectrometry.
Park J; Cha DH; Jung JW; Kim YH; Lee SH; Kim Y; Kim KP
J Microbiol Biotechnol; 2010 Jun; 20(6):959-67. PubMed ID: 20622492
[TBL] [Abstract][Full Text] [Related]
5. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
Yu B; Zhang B; Wang J; Wang QW; Huang RP; Yang YQ; Shao SH
Exp Biol Med (Maywood); 2012 May; 237(5):530-9. PubMed ID: 22678011
[TBL] [Abstract][Full Text] [Related]
6. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
Martínez-Morillo E; Cho CK; Drabovich AP; Shaw JL; Soosaipillai A; Diamandis EP
J Proteome Res; 2012 Jul; 11(7):3880-7. PubMed ID: 22681384
[TBL] [Abstract][Full Text] [Related]
7. The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome.
Heywood W; Wang D; Madgett TE; Avent ND; Eaton S; Chitty LS; Mills K
J Proteomics; 2012 Jun; 75(11):3248-57. PubMed ID: 22543281
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid NF-kB concentration in pregnant women with a high risk of prenatal screening test results.
Arpacı H; Yapca OE
Ginekol Pol; 2018; 89(10):577-580. PubMed ID: 30393848
[TBL] [Abstract][Full Text] [Related]
9. Qualification and Verification of Protein Biomarker Candidates.
Zhao Y; Brasier AR
Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid.
Perluigi M; di Domenico F; Fiorini A; Cocciolo A; Giorgi A; Foppoli C; Butterfield DA; Giorlandino M; Giorlandino C; Schininà ME; Coccia R
Proteomics Clin Appl; 2011 Apr; 5(3-4):167-78. PubMed ID: 21360684
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
[TBL] [Abstract][Full Text] [Related]
13. Combining selected reaction monitoring with discovery proteomics in limited biological samples.
Gupta MK; Jung JW; Uhm SJ; Lee H; Lee HT; Kim KP
Proteomics; 2009 Nov; 9(21):4834-6. PubMed ID: 19810035
[TBL] [Abstract][Full Text] [Related]
14. Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome.
Laudanski P; Zbucka-Kretowska M; Charkiewicz K; Wolczynski S; Wojcik D; Charkiewicz R
Mediators Inflamm; 2014; 2014():835837. PubMed ID: 25477715
[TBL] [Abstract][Full Text] [Related]
15. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.
Muraoka S; Kume H; Watanabe S; Adachi J; Kuwano M; Sato M; Kawasaki N; Kodera Y; Ishitobi M; Inaji H; Miyamoto Y; Kato K; Tomonaga T
J Proteome Res; 2012 Aug; 11(8):4201-10. PubMed ID: 22716024
[TBL] [Abstract][Full Text] [Related]
16. [Practicality of rapid prenatal screening for Down syndrome with PCR-short tandem repeat method].
Guan L; Ren C; Li H; Gao L; Jia N; Guan H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):277-82. PubMed ID: 23744314
[TBL] [Abstract][Full Text] [Related]
17. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome.
Perrone S; Longini M; Bellieni CV; Centini G; Kenanidis A; De Marco L; Petraglia F; Buonocore G
Clin Biochem; 2007 Feb; 40(3-4):177-80. PubMed ID: 17208212
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of trisomy 21 by quantitatively pyrosequencing heterozygotes using amniotic fluid as starting material of PCR.
Ye H; Wu H; Huang H; Liu Y; Zou B; Sun L; Zhou G
Analyst; 2013 Apr; 138(8):2443-8. PubMed ID: 23463136
[TBL] [Abstract][Full Text] [Related]
19. A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
Chen L; Smith J; Mikl J; Fryer R; Pack F; Williams BJ; Phillips JA; Papov VV
Chem Res Toxicol; 2017 Oct; 30(10):1823-1834. PubMed ID: 28885000
[TBL] [Abstract][Full Text] [Related]
20. Determination of selected reaction monitoring peptide transitions via multiplexed product-ion scan modes.
Cho BK; Koo YD; Kim K; Kang MJ; Lee YY; Kim Y; Park KS; Kim KP; Yi EC
Rapid Commun Mass Spectrom; 2014 Apr; 28(7):773-80. PubMed ID: 24573808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
